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أسبرييغيلوس فوميغاتوس بني السكان البالغني العمانيني
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abstract: Objectives: The presence of abnormally high levels of Aspergillus fumigatus-specific immunoglobulin 
(Ig) G antibodies can serve as a diagnostic criterion for severe conditions like allergic bronchopulmonary and chronic 
pulmonary aspergillosis. This study aimed to determine a reference range of A. fumigatus-specific IgG levels within a 
healthy adult Omani population. Methods: This study took place during November 2015 at the Sultan Qaboos 
University Hospital, Muscat, Oman. The sera of 125 healthy Omani blood donors were tested for A. fumigatus-
specific IgG levels using an automated fluorescence enzyme immunoassay. Results: Initially, the data were not 
normally distributed; however, log transformation and the exclusion of four outliers resulted in an acceptable 
Gaussian distribution. The reference range was 2.0–68.7 mgA/L at the 2.5
th and 97.5th percentiles, respectively, 
with 90% confidence intervals of 2.0–3.0 mgA/L and 48.0–76.0 mgA/L, respectively. Conclusion: The A. fumigatus-
specific IgG reference range within a healthy adult Omani population was comparable to those reported in other 
populations.
Keywords: Aspergillus fumigatus; Allergic Bronchopulmonary Aspergillosis; Pulmonary Aspergillosis; Immuno-
globulin G; Reference Range; Oman.
يعترب  احلالتني  كلتي  ويف  فطري.  اإلتهاب  اأو  ح�سا�سية  اإحداث  خالل  من  لالإن�سان  خمتلفة  اأمرا�ض  الر�سا�سيات  ت�سبب  الهدف:  امللخ�ص: 
الق�سبي  الر�سا�سيات  داء  لت�سخي�ض  الرئي�سة  الركائز  اأحد  فوميغاتو�ض  للر�سا�سيات   )G )نوع  امل�سادة  املناعية  االأج�سام  م�ستوى  حتديد 
الرئوي التح�س�سي اأو داء الر�سا�سيات الرئوي املزمن. وال يوجد حاليا معدل مرجعي �سواء اأكان حمليا اأو اإقليميا ميكن ا�ستخدامه لدعم هذه 
G( للر�سا�سيات فوميغاتو�ض.  )نوع  اإىل حتديد امل�ستوى املرجعي مل�ستوى االأج�سام املناعية امل�سادة  الدرا�سة  الت�سخي�سات. هدفت هذه 
الطريقة: اأجريت هذه الدرا�سة خالل �سهر نوفمرب2015 يف م�ست�سفى جامعة ال�سلطان قابو�ض، م�سقط، �سلطنة عمان اىلمت فح�ض جمموعة 
من العينات ماأخوذة من االأ�سحاء العمانيني املتربعني بالدم والبالغ عددهم 125 وذلك با�ستخدام نظام اإميونوكاب من فاديا اأوب�ساال، 
 )G )نوع  االأج�سام املناعية امل�سادة  االأولية  مل�ستوى  القيا�سات  النتائج: مل تتبع  العلمية(.  االآن با�سم احلرارية في�رص  )املعروفة  ال�سويد 
للر�سا�سيات فوميغاتو�ض منحنى املعدل الطبيعي مما تتطلب تطبيق التحويل اللوغاريثمي على البيانات والذى اأدى بدوره اإىل احل�سول 
على توزيع طبيعي ومقبول للبيانات. ومن ثم مت ح�ساب امل�ستوى املرجعي لالأج�سام املناعية امل�سادة )نوع G( للر�سا�سيات فوميغاتو�ض 
با�ستخدام طريقة الن�سب املئوية 2.5th و 97.5th وات�سح انها ترتاوح بني 2.0 مليغرام/لرت و 68.7 مليغرام/لرت بفوا�سل ثقة %90 ترتاوح 
 )G )نوع  امل�سادة  املناعية  لالأج�سام  املرجعي  امل�ستوى  اخلال�صة:  التوايل.  على  مليغرام/لرت   48.0–76.0 و  مليغرام/لرت   2.0–3.0 بني 
للر�سا�سيات فوميغاتو�ض للبالغني االأ�سحاء العمانيني م�سابه ملا مت ر�سده يف جمتمعات اخرى.
الكلمات املفتاحية: الر�سا�سيات فوميغاتو�ض؛ داء الر�سا�سيات الق�سبي الرئوي التح�س�سي؛ داء الر�سا�سيات الرئوي املزمن؛ امل�ستوى املرجعي؛ 
عمان.
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Advances in Knowledge 
- To the best of the authors’ knowledge, this study is the first in Oman and the Arabian Gulf region to evaluate the reference range of 
Aspergillus fumigatus-specific immunoglobulin G (IgG) levels in a local population.
Application to Patient Care
- The findings of the current study may guide clinicians in establishing diagnoses of allergic bronchopulmonary aspergillosis and chronic 
pulmonary aspergillosis at the Sultan Qaboos University Hospital, Muscat, Oman.
The Aspergillus genus is an extremely abundant type of airborne fungi constantly inhaled by humans which, for the most 
part, does not cause significant illness; however, 
individuals with pre-existing lung pathologies or weak- 
ened immune systems can develop Aspergillus-related 
diseases known as aspergillosis.1 Most cases of asper- 
gillosis are caused by A. fumigatus (80%), although other 
species can also cause infection, such as A. flavus, 
A. terreus and A. niger.1–3 Aspergillosis caused by 
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A. fumigatus presents with either allergies—including 
allergic Aspergillus sinusitis and allergic bronchopul-
monary aspergillosis (ABPA)—or infections, such as 
local aspergillomas affecting the lungs and sinuses, 
necrotising chronic pulmonary aspergillosis (CPA) 
and systemic invasive aspergillosis.4–6 
Usually, ABPA or CPA is diagnosed following 
assessment of the patient’s medical history for risk 
factors, a physical examination, radiological imaging and 
laboratory investigations. To this end, elevated levels of 
A. fumigatus-specific immunoglobulin (Ig) G antibodies 
are considered the main clinical criterion to support the 
diagnosis.4 However, there is currently no published 
reference range of anti-A. fumigatus-specific IgG levels 
for healthy adult populations in Arab countries. There- 
fore, the aim of this study was to establish a reference 
range for A. fumigatus-specific IgG antibodies in an 
Omani population. Hopefully, this reference range will 
guide clinicians in Oman when establishing diagnoses 
of ABPA and CPA.
Methods
This study took place in November 2015 at the Sultan 
Qaboos University Hospital (SQUH) in Muscat, Oman. 
Samples of sera were collected from 125 healthy adult 
donors attending the SQUH Blood Bank during the 
study period. Only healthy adult donors without any 
previous history of lung disease or asthma and no prior 
significant exposure to birds were included. Four out- 
liers were excluded from the initial sample; however, 
the final sample of 121 subjects complied with the 
minimum sample size recommended by the Clinical 
and Laboratory Standards Institute (CLSI) for establish- 
ing a reference range.7–9
A total of 5–10 mL of blood was obtained from 
each subject. The sera were immediately separated and 
stored at -80 °C until analysis. Specific IgG antibodies 
against A. fumigatus were determined using an auto- 
mated fluorescence enzyme immunoassay (Immuno-
CAP® system, Thermo Fisher Scientific Inc., Phadia AB, 
Uppsala, Sweden), as per the manufacturer’s instruc-
tions. The assay was performed by an experienced senior 
biomedical scientist in the Immunology Laboratory 
of SQUH. Results were expressed as milligrams of 
Aspergillus-specific IgG antibodies per litre (mgA/L). 
All reagents were received from the same lot number 
and each run included internal quality control samples. 
The interassay coefficient of variation between runs 
for the quality control samples was <10%, as per the 
manufacturer’s instructions. 
Data were analysed using the MedCalc® statistical 
software package, Version 16.4.3 (MedCalc Software, 
Ostend, Belgium). A non-parametric percentile method 
following the CLSI guidelines was used on log-trans-
formed data to establish the reference range at a 90% 
confidence interval (CI).8,9 The level of statistical signifi-
cance was set at P <0.050.
Ethical approval for this study was obtained from 
the Research & Ethics Committee of the College of 
Medicine & Health Sciences, Sultan Qaboos University 
(MREC #1220-A). All subjects gave informed written 
consent prior to their participation in the study.
Results
The median age of the subjects was 24 years (range: 
18–52 years old). Most of the donors were male, with 
a female-to-male ratio of 1:9.3. Initially, a frequency 
histogram and quantile-quantile plot to assess the distri- 
bution of the collected data indicated that the data 
were not normally distributed [Figure 1]. This finding 
was further supported by the results of a D’Agostino-
Pearson test (P <0.001). Accordingly, the data were 
log-transformed for subsequent analysis. However, 
the data were still not normally distributed [Figure 2]. 
A Tukey’s test identified four outliers, the exclusion of 
which resulted in the normal Gaussian distribution of 
the log-transformed data of the remaining 121 samples 
[Figure 3]. The reference range of A. fumigatus-specific 
Figure 1: A: Relative frequency histogram of Aspergillus fumigatus-specific immunoglobulin G (IgG) antibodies in the 
sera of healthy Omani blood donors (N = 125). B: Quantile-quantile plot of results obtained for A. fumigatus-specific IgG 
antibodies in the sera of healthy Omani blood donors (N = 125).
IgG = immunoglobulin G.
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IgG for these 121 samples was 2.0–76.0 mgA/L, with a geo- 
metric mean of 10.9 mgA/L and median of 11.0 mgA/L. 
The 2.5th percentile was 2.0 mgA/L with a 90% CI 
of 2.0–3.0 mgA/L and the 97.5
th percentile was 
68.7 mgA/L with a 90% CI of 48.0–76.0 mgA/L.
Discussion
Although uncommon, both ABPA and CPA are serious 
diseases that can affect immunocompetent patients with 
underlying lung pathologies. The former is a severe 
allergic and inflammatory condition that predomi-
nantly affects patients with asthma or cystic fibrosis 
and presents with fever, cough, shortness of breath, 
wheezing and haemoptysis; moreover, patients become 
sensitised to A. fumigatus, causing significant morbidity 
and mortality.10 Immunological mechanisms in ABPA 
that result in pathology are mainly type I immediate 
and type III immune complex hypersensitivity reactions 
mediated by IgE and IgG antibodies, respectively.4 
The primary treatment for ABPA is oral cortico-
steroids to control the inflammatory process, while 
anti-fungals are used only as an adjuvant therapy in 
order to reduce the fungal load.9
In contrast, CPA is a chronic lung infection that 
can progress to pulmonary fibrosis and loss of lung 
function; the disease presents with constitutional and 
respiratory symptoms including weight loss, fatigue, 
shortness of breath and haemoptysis.10 In general, 
CPA affects immunocompetent  patients with pre- 
existing lung conditions as opposed to invasive asper-
gillosis, which usually occurs in immunocompromised 
patients.11 Underlying lung comorbidities which may 
predispose a patient to CPA include chronic obstruct-
ive pulmonary disease, pre-existing pulmonary cavitary 
tuberculosis, fibrotic sarcoidosis and ABPA. In some 
cases, CPA can manifest as a simple aspergilloma, 
chronic cavitary pulmonary aspergillosis, chronic fibro- 
sing pulmonary aspergillosis, subacute invasive asper- 
gillosis and aspergillosis nodules.11,12 For most patients, 
CPA is treated with antifungal agents and surgery. 
However, interferon-γ has been recently proposed as 
an adjuvant therapy.4
In the current study, the reference range of 
A. fumigatus-specific IgG levels among a sample of 
healthy adult Omani blood donors was found to be 
2.0–68.7 mgA/L using the percentile method. This refer-
ence range was comparable to other published ranges 
Figure 2: A: Relative frequency histogram of log-transformed Aspergillus fumigatus-specific immunoglobulin G (IgG) 
antibodies in the sera of healthy Omani blood donors (N = 125). B: Quantile-quantile plot of log-transformed data for 
A. fumigatus-specific IgG antibodies in the sera of healthy Omani blood donors (N = 125).
IgG = immunoglobulin G.
Figure 3: A: Relative frequency histogram of log-transformed Aspergillus fumigatus-specific immunoglobulin G (IgG) 
antibodies in the sera of healthy Omani blood donors (N = 121). B: Quantile-quantile plot of log-transformed data for 
A. fumigatus-specific IgG antibodies in the sera of healthy Omani blood donors (N = 121).
IgG = immunoglobulin G.
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and can potentially be used in conjunction with other 
parameters to diagnose patients suspected of having 
ABPA or CPA. Utilising the same immunoassay as that 
of the current study, Watkins et al. found the reference 
range of A. fumigatus-specific IgG levels to be 
2.79–66.45 mgA/L in a group of 122 healthy adults in 
South Africa.13 The same method and assay techno-
logy was used to detect an A. fumigatus-specific IgG 
range of 2.01–70.10 mgA/L in a group of 42 healthy 
individuals in Belgium.14 An enzyme-linked immuno- 
sorbent assay yielded similar results when assessing 
A. fumigatus IgG levels among 100 healthy Finnish 
children between 7–13 years old to the 95th percentile 
(67.8–68.3 mg/L); in addition, the researchers observed 
that A. fumigatus-specific IgG concentrations increased 
with age to reach a plateau at 6–7 years old, although 
the concentrations were not affected by gender.15 
Agarwal et al. compared 67 patients with ABPA to 32 
asthmatic controls in India; using a receiver operated 
characteristic curve, the researchers determined the 
ideal cut-off value for A. fumigatus-specific IgG to be 26.9 
mgA/L.
16 However, it is important to note that the controls 
in this study were a small cohort of diseased rather than 
healthy individuals.16
To the best of the authors’ knowledge, this study 
is the first in the Arabian Gulf region to derive a 
reference range for A. fumigatus-specific IgG levels in 
a cohort of healthy donors. In addition, the sample size 
was adequate in comparison to other studies and 
complied with CLSI recommendations.8,9,17 Neverthe-
less, this study was limited in that patients with ABPA 
or CPA were not included. Such patients should there- 
fore be included in future research so as to validate 
the reference range determined. In addition, due to 
a lack of female patients within the cohort, no differ-
ences in A. fumigatus-specific IgG levels were noted 
between genders.
Conclusion 
In summary, A. fumigatus-specific IgG levels are an 
important diagnostic parameter for patients with ABPA 
or CPA. In the current study, the reference range of 
A. fumigatus-specific IgG levels in healthy Omani donors 
was found to be 2.0–68.7 mgA/L at the 2.5
th and 97.5th 
percentiles, respectively. This reference range was 
comparable to other published ranges reported from 
different populations worldwide.
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